GlassScriptPhysician profile
Stephanie Spaight
NPI 1295218444
$4,590.02
in general payments reported to CMS, 2019-2025
42 companies · $797 in 2025
The $797 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $423 · 2022: $1,577 · 2023: $1,090 · 2024: $703 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,589.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $773.97 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $638.53 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $384.12 | 2022-2025 | |
| Abbvie INC. | $380.03 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $354.34 | 2021-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $229.36 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $203.68 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.73 | 2022-2025 | Jardiance |
| Antares Pharma, INC. | $166.00 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $139.12 | 2021-2025 | Veozah |
| Althera Pharmaceuticals LLC | $118.06 | 2022 | |
| Exact Sciences Corporation | $95.49 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $87.52 | 2021-2025 | |
| Dexcom, INC. | $79.15 | 2021-2025 | Dexcom G6 Transmitter |
| Nestle Healthcare Nutrition INC. | $75.90 | 2022-2023 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Spaight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.